ROBERT HAGEMANN - 31 Dec 2022 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role: Director
Signature: /s/ Matthew R. St. Louis, Attorney-in-Fact for Robert A. Hagemann (power of attorney previously filed)
Issuer symbol: ZBH
Transactions as of: 31 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Jan 2023, 15:12:47 UTC
Previous filing: 19 Dec 2022
Next filing: 04 Apr 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZBH	Phantom Stock Units	Award	$0	+266	+1.1%	$0.000000	25,423	31 Dec 2022	Common Stock	266	$126.97	Direct	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2	The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3	Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.
F4	Includes 53.327 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.